News
The FDA has granted Fast Track designation to rezpegaldesleukin for the treatment of severe to very severe alopecia areata.
Pre-exposure administration of the JYNNEOS vaccine was associated with reduced disease severity in cisgender men and boys with confirmed mpox.
The risk for several ocular and auditory comorbidities is increased in children, adolescents, and adults with vitiligo compared with control patients.
Dr Susan Monarez was confirmed as director of the CDC by the Senate on Tuesday after serving as the agency’s acting director since March.
The FDA has approved Anzupgo (delgocitinib) cream for the topical treatment of moderate to severe chronic hand eczema in ...
Benefits of 7000 steps per day include lower risk for death and cardiovascular disease, diabetes, dementia, and depression.
Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.
RFK Jr may remove all 16 members of the advisory group that helps decide which preventive services are fully covered by insurance.
The loved ones of those with cancer report an emotional burden, including concerns about life expectancy, course of treatment, and pain.
With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.
The FDA has appointed George Francis Tidmarsh, MD, PhD, to be the director of the Center for Drug Evaluation and Research.
There was a 1% increase in the number of births and a 1% decrease in the general fertility rate from 2023 to 2024.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results